In lung cancer, miR-377-5p inhibits cell development and regulated cell cycle distribution and epithelial to mesenchymal transition (EMT) by targeting AKT144 and reduces cell proliferation, promotes apoptosis in non-small lung cancer by targeting CDK6 and AEG-145,46. Here, CDK6 is linked to lung carcinoma.